(Date:12/1/2009)...RESEARCH TRIANGLE PARK, N.C., Dec. 1 /PRNewswire/ ...2001 and have expanded over the years serving the ...cility which was originally set up in an area of 2...ices, as part of the suite of services by Max Neem...s a valuable offering. ,, The pharmacy inventor...
(Date:12/1/2009)...SHINGTON, Dec. 1 Indivi...more likely than those with traditional coverage t... be more engaged in wellness programs, and to be m...tter in holding down costs, according to survey re...enefit Research Institute (EBRI). ,, At the sa...
(Date:12/1/2009)...ORT LAUDERDALE, Fla., Dec. 1 Orbus...rollment in the randomized clinical trial of the C... Stent). ,, A prospective, randomized, multicen...of an ablu M inal sirolimus coat ED bio- E ...p to 20 sites in Asia, Australia, Europe and South...
(Date:12/1/2009)...ients in California are unable to successfully obt...hospitals despite recent state legislation intende...w study. , Posing as low-income uninsured patien... than one-third of the hospitals they approached a...han those allowed under California law, according ...
(Date:12/1/2009)... Lumension announces general availabilit...e to deliver end-to-end endpoint management capabi... management console architecture. , ... -- Lumension, a global leader in endpoint managem...n® Endpoint Management and Security Suite (LEM...
Breaking Medicine News(10 mins):Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 2Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 3Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 4Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4Health News:Hospital price transparancy laws in California fall short, study finds 2Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 2Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 3Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 4Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 5Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 6